Digital Interventions für Prävention, Management und Behandlung von Krankheiten
Für die Bewältigung globaler Herausforderungen wie die alternde Bevölkerung und die steigende Zahl nichtübertragbarer Krankheiten sind digitale Innovationen erforderlich. Unsere Forschung und Innovationsgeist zielen darauf ab, neue Massnahmen im Bereich der Digital Health Interventions zu entwickeln und bereitzustellen, um die Gesundheit über den gesamten Lebensverlauf hinweg zu stärken und den Zugang zur Gesundheitsversorgung zu ermöglichen. Wir entwickeln präventive Massnahmen zur Förderung gesunder Verhaltensweisen und digitale Therapeutika für chronische Krankheiten wie Asthma und Depression.
Unsere Forschung befasst sich mit den Kernelementen erfolgreicher Digital Health Interventions einschliesslich der Entwicklung digitaler Therapeutika und Biomarker, der Entwicklung von "just-in-time adaptive interventions", der Bestimmung der Rezeptivität für Interventionen und dem besseren Zugang zur Gesundheitsversorgung dank Digital Interventions.
Wir sind Teil des Centre for Digital Health Interventions und des CAS ETH in Digital Health.
Latest News CDHI
-
Webinar: How to deliver safe and effective agentic health interventions?
Webinar: How to deliver safe and effective agentic health interventions? Agentic systems are quickly moving beyond “chat” toward interventions that can plan, personalize, monitor, and take actions across time. In Precision Digital Therapeutics (PDTx), that creates a unique bar: it is not enough to [...]
-
REVELIO Study on driving under the influence of cannabis is recruiting participants
The REVELIO Study, a project out of CDHI's Core for Digital Biomarkers in Driver Health and Safety, is recruiting participants. Background of the study: People who regularly consume cannabis have elevated blood concentrations of THC for days after the consumation. Due to a zero tolerance regulation, they [...]
-
Join the Core for Adaptive Intelligence and Mental Health at the ACNP Annual Meeting
We are delighted to share that Nadja Ging-Jehli, PhD (Core Director for Adaptive Intelligence and Mental Health Mechanisms at CDHI) has been awarded a Travel Award from the American College of Neuropsychopharmacology (ACNP) to attend the 2026 ACNP Annual Meeting. The award recognizes outstanding early-career researchers whose [...]
-
A warm welcome to Christoph Karl Heck
We are delighted to welcome Christoph Karl Heck as a PhD student at the Centre for Digital Health Interventions (CDHI) at ETH Zürich, as part of the Core Digital Biomarkers in Driver Health and Safety, working on the Revelio study. His focus is detecting cannabis-impaired [...]
-
A warm welcome to Michal Bechny
We are delighted to welcome Michal Bechny as a postdoctoral researcher to the Centre for Digital Health Interventions (CDHI) at ETH Zürich, as part of the Core Digital Biomarkers in Driver Health and Safety. His focus is applied machine learning for detecting driving impairment and [...]